Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6.230 KRW | 0,00% |
|
-8,11% | -69,61% |
Attività
Vendite per attività
KRW in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Health Functional Food
100,0
%
| 31 | 100,0 % | 14 | 100,0 % | -56,00% |
Vendite per regione
KRW in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 31 | 100,0 % | 14 | 100,0 % | -56,00% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Hoi-Yoon Jung
CEO | Chief Executive Officer | 45 | - |
Seon-Wook Hwang
CEO | Chief Executive Officer | 64 | 04/11/10 |
Heon-Jong Lee
BRD | Director/Board Member | 54 | 01/04/11 |
Johan Auwerx
BRD | Director/Board Member | - | - |
Chun-Su Lee
AUD | Comptroller/Controller/Auditor | 62 | 31/03/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Johan Auwerx
BRD | Director/Board Member | - | - |
Seon-Wook Hwang
CEO | Chief Executive Officer | 64 | 04/11/10 |
Heon-Jong Lee
BRD | Director/Board Member | 54 | 01/04/11 |
Mun-Jin Song
BRD | Director/Board Member | 54 | 01/01/14 |
Sang-Joon Kim
BRD | Director/Board Member | 63 | 15/06/18 |
In-Gyu Lee
BRD | Director/Board Member | 67 | 13/12/17 |
Jong-Man Seol
BRD | Director/Board Member | 65 | 27/03/19 |
Gyung-Tae Kim
BRD | Director/Board Member | 67 | 21/09/16 |
Hoi-Yoon Jung
CEO | Chief Executive Officer | 45 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 11 090 448 | 7 443 358 ( 67,12 %) | 135 ( 0,001217 %) | 67,12 % |
Coordinate società
![Indirizzo NovMetaPharma Co., Ltd.(A229500)](https://cdn.zonebourse.com/static/address/120972868.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-69,61% | 40,39 Mln | |
+21,00% | 127 Mrd | |
+23,61% | 116 Mrd | |
+25,15% | 27,69 Mrd | |
-19,30% | 19,62 Mrd | |
-16,57% | 16,26 Mrd | |
-16,51% | 15,49 Mrd | |
+11,62% | 14,81 Mrd | |
-46,65% | 14,39 Mrd | |
+55,81% | 14,11 Mrd |
- Borsa valori
- Azioni
- Azione A229500
- Società NovMetaPharma Co., Ltd.